|
| COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms |
|
https://doi.org/10.18632/oncotarget.28824
Charlotte Kuperwasser, and Wafik S. El-Deiry
|
| 1-29 |
|
| Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53 |
|
https://doi.org/10.18632/oncotarget.28823
Wafik S. El-Deiry
|
| 30-33 |
|
| Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms |
|
https://doi.org/10.18632/oncotarget.28827
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, Masanori Fukushima, and Panagis Polykretis
|
| 34-49 |
|
| Censorship in science: How publishing decisions could have shaped the perceived “general consensus” on COVID-19 vaccine safety and efficacy |
|
https://doi.org/10.18632/oncotarget.28829
Panagis Polykretis, Janci C. Lindsay, Patrizia Gentilini, Nafuko Konishi, and Masanori Fukushima
|
| 50-53 |
|
| CAR-T therapy: Trailblazing CAR(ing) in cancer treatment |
|
https://doi.org/10.18632/oncotarget.28836
Uzma Saqib, Monika Pandey, and Krishnan Hajela
|
| 54-56 |
|
| Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells |
|
https://doi.org/10.18632/oncotarget.28846
Steven A. Greenberg
|
| 57-58 |
|
| CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer |
|
https://doi.org/10.18632/oncotarget.28826
Allison Makovec, John T. Phoenix, Hannah E. Bergom, Ella Boytim, Ava P. Gustafson, Aiden Deacon, Sydney Tape, Atef Ali, Megan Ludwig, Samuel P. Pitzen, David Moline, Camden Richter, Hudson Longie, Mei-Chi Su, Sampreeti Jena, Pornlada Likasitwatanakul, Justin M. Drake, R. Stephanie Huang, William C. Hahn, Jonathan P. Rennhack, Scott M. Dehm, Steven Kregel, Emmanuel S. Antonarakis, and Justin Hwang
|
| 59-73 |
|
| Correction: Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation |
|
https://doi.org/10.18632/oncotarget.28845
Antonio Bilancio, Paola Bontempo, Marzia Di Donato, Mariarosaria Conte, Pia Giovannelli, Lucia Altucci, Antimo Migliaccio, and Gabriella Castoria
|
| 74-75 |
|
| Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism |
|
https://doi.org/10.18632/oncotarget.28844
Claudia Fumarola, Daniele Cretella, Silvia La Monica, Mara A. Bonelli, Roberta Alfieri, Cristina Caffarra, Federico Quaini, Denise Madeddu, Angela Falco, Andrea Cavazzoni, Graziana Digiacomo, Giulia Mazzaschi, Valentina Vivo, Elisabetta Barocelli, Marcello Tiseo, Pier Giorgio Petronini, and Andrea Ardizzoni
|
| 76-77 |
|
| The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells |
|
https://doi.org/10.18632/oncotarget.28861
Michael R. Booth, Laurence Booth, Jane L. Roberts, John M. Kirkwood, and Paul Dent
|
| 78-89 |
|
| Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses |
|
https://doi.org/10.18632/oncotarget.28851
Kayode Ahmed, and Juan E. Núñez-Ríos
|
| 90-118 |
|
| Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin |
|
https://doi.org/10.18632/oncotarget.28835
Lin-Hai Yan, Zhi-Ning Chen, Li-Li, Jia Chen, Wen-E Wei, Xian-Wei Mo, Yu-Zhou Qin, Yuan Lin, and Jian-Si Chen
|
| 119-119 |
|
| Efficacy and safety of PD-1/ PD-L1 inhibitors as adjuvants in the treatment of patients with solid cancers: A systematic review and meta-analysis of randomized controlled trials |
|
https://doi.org/10.18632/oncotarget.28855
Maryam Aleid, Fatimah Aleid, Daniah Allbdi, Ahmad Rchdeih, Dhai Almuteri, Abdulelah Almesned, Samaa Alotab, Yumna AlMishary, Galia Alsamman, and Atlal Abusanad
|
| 120-135 |
|
| Correction: LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions |
|
https://doi.org/10.18632/oncotarget.28843
Fakeng Liu, Rui Jin, Xiuju Liu, Henry Huang, Scott C. Wilkinson, Diansheng Zhong, Fadlo R. Khuri, Haian Fu, Adam Marcus, Yulong He, and Wei Zhou
|
| 136-136 |
|
| Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer |
|
https://doi.org/10.18632/oncotarget.28842
Gonzalo Sequeira, Silvia I Vanzulli, Paola Rojas, Caroline Lamb, Lucas Colombo, María May, Alfredo Molinolo, and Claudia Lanari
|
| 137-138 |
|
| Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings |
|
https://doi.org/10.18632/oncotarget.28856
Pragnesh Parmar, and Gunvanti Rathod
|
| 139-155 |
|
| Retraction: Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis |
|
https://doi.org/10.18632/oncotarget.28834
Lili Yang, Gongliang Guo, Liqun Sun, Chenhao Li, and Haipeng Zhang
|
| 156-156 |
|
| Epigenetic dysregulation and biological function of PDX1 in prostate cancer |
|
https://doi.org/10.18632/oncotarget.28854
Tayo A. Adeyika, Anju Datturgi, Yehnara Ettinoffe, Somiranjan Ghosh, Christopher Albanese, and Bernard Kwabi-Addo
|
| 157-172 |
|
| Oncotarget: Past, Present and Future: Trends in the publishing industry |
|
https://doi.org/10.18632/oncotarget.28852
Scientific Integrity Office at Oncotarget
|
| 173-177 |
|
| Retraction: Role of the PEBP4 protein in the development and metastasis of gastric cancer |
|
https://doi.org/10.18632/oncotarget.28875
Zijian Wu, Bin Liu, Xuemin Zheng, Huijing Hou, and Ying Li
|
| 178-178 |
|
| Retraction: Inhibition of endoplasmic reticulum stress alleviates cigarette smoke-induced airway inflammation and emphysema |
|
https://doi.org/10.18632/oncotarget.28876
Yong Wang, Zhen-Zhen Wu, and Wei Wang
|
| 179-179 |
|
| Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.28833
Tiantian Wang, Mei Wang, Shuang Fang, Qiang Wang, Rui Fang, and Jie Chen
|
| 180-181 |
|
| Retraction: By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth |
|
https://doi.org/10.18632/oncotarget.28830
Zheng Li, Xin Yu, Yang Wang, Jianxiong Shen, William Ka Kei Wu, Jinqian Liang, and Fan Feng
|
| 182-183 |
|
| Retraction: Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells |
|
https://doi.org/10.18632/oncotarget.28832
Yuedi Dai, Meixing Wang, Haixia Wu, Mi Xiao, Houbao Liu, and Dexiang Zhang
|
| 184-184 |
|
| Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.28847
Bo Tang, Guangying Qi, Fang Tang, Shengguang Yuan, Zhenran Wang, Xingsi Liang, Bo Li, Shuiping Yu, Jie Liu, Qi Huang, Yangchao Wei, Run Zhai, Biao Lei, Hongping Yu, Xingyuan Jiao, and Songqing He
|
| 185-186 |
|
| Retraction: Effect and mechanism of inhibition of PI3K/Akt/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury |
|
https://doi.org/10.18632/oncotarget.28848
Jian-Rong Guo, Huan Wang, Xiao-Ju Jin, Dong-Lin Jia, Xun Zhou, and Qiang Tao
|
| 187-187 |
|
| Retraction: Sodium fluoride induces apoptosis in mouse splenocytes by activating ROS-dependent NF-κB signaling |
|
https://doi.org/10.18632/oncotarget.28849
Huidan Deng, Ping Kuang, Hengmin Cui, Qin Luo, Huan Liu, Yujiao Lu, Jing Fang, Zhicai Zuo, Junliang Deng, Yinglun Li, Xun Wang, and Ling Zhao
|
| 188-188 |
|
| Retraction: Effects of microRNA-19b on airway remodeling, airway inflammation and degree of oxidative stress by targeting TSLP through the Stat3 signaling pathway in a mouse model of asthma |
|
https://doi.org/10.18632/oncotarget.28841
Ling Ye, Yan Mou, Jian Wang, and Mei-Ling Jin
|
| 189-189 |
|
| Retraction: QKI5mediated alternative splicing of the histone variant macroH2A1 regulates gastric carcinogenesis |
|
https://doi.org/10.18632/oncotarget.28866
Feng Li, Ping Yi, Jingnan Pi, Lanfang Li, Jingyi Hui, Fang Wang, Aihua Liang, and Jia Yu
|
| 190-191 |
|
| Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.28873
Xin Zheng, Tao Song, Changwei Dou, Yuli Jia, and Qingguang Liu
|
| 192-192 |
|
| Retraction: Lycium barbarum polysaccharides inhibit proliferation and migration of bladder cancer cell lines BIU87 by suppressing Pi3K/AKT pathway |
|
https://doi.org/10.18632/oncotarget.28839
Xian-Jun Zhang, Hong-Yuan Yu, Yong-Jian Cai, and Mang Ke
|
| 193-194 |
|
| Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.28869
Xin Liu, Liu Yang, Jianfeng Tu, Wenwei Cai, Meiqi Zhang, Zhangxuan Shou, Yingmin Yao, and Qiuran Xu
|
| 195-196 |
|
| Retraction: LncRNA CHRFinduced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway |
|
https://doi.org/10.18632/oncotarget.28868
Youmao Tao, Tao Han, Tao Zhang, Chong Ma, and Caixia Sun
|
| 197-198 |
|
| Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2 |
|
https://doi.org/10.18632/oncotarget.28837
Guixing Jiang, Yunfu Cui, Xin Yu, Zhengrong Wu, Guoping Ding, and Liping Cao
|
| 199-200 |
|
| Retraction: Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis |
|
https://doi.org/10.18632/oncotarget.28860
Ziliang Wang, Yang Liu, Lili Lu, Lina Yang, Sheng Yin, Yan Wang, Zihao Qi, Jiao Meng, Rongyu Zang, and Gong Yang
|
| 201-201 |
|
| Retraction: Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC |
|
https://doi.org/10.18632/oncotarget.28865
Teng-Fei Fan, Lin-Lin Bu, Wei-Ming Wang, Si-Rui Ma, Jian-Feng Liu, Wei-Wei Deng, Liang Mao, Guang-Tao Yu, Cong-Fa Huang, Bing Liu, Wen-Feng Zhang, and Zhi-Jun Sun
|
| 202-202 |
|
| Retraction: Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM |
|
https://doi.org/10.18632/oncotarget.28840
Weidong Li, Xiaobo Miao, Lingling Liu, Yue Zhang, Xuejun Jin, Xiaojun Luo, Hai Gao, and Xubin Deng
|
| 203-203 |
|
| Retraction: MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1 |
|
https://doi.org/10.18632/oncotarget.28838
Songyu Tian, Mingyue Zhang, Xiuwei Chen, Yunduo Liu, and Ge Lou
|
| 204-204 |
|
| Retraction: JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer* |
|
https://doi.org/10.18632/oncotarget.28864
Haifeng Qiu, Amanda L. Jackson, Joshua E. Kilgore, Yan Zhong, Leo Li-Ying Chan, Paola A. Gehrig, Chunxiao Zhou, and Victoria L. Bae-Jump
|
| 205-205 |
|
| Retraction: JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer |
|
https://doi.org/10.18632/oncotarget.28867
Haifeng Qiu, Jing Li, Leslie H. Clark, Amanda L. Jackson, Lu Zhang, Hui Guo, Joshua E. Kilgore, Paola A. Gehrig, Chunxiao Zhou, and Victoria L. Bae-Jump
|
| 206-206 |
|
| Correction: S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting MicroRNA 34a/b-methionine adenosyltransferase 2A/2B axis |
|
https://doi.org/10.18632/oncotarget.28858
Maria Lauda Tomasi, Carla Cossu, Ylenia Spissu, Andrea Floris, Minjung Ryoo, Ainhoa Iglesias-Ara, Qiang Wang, Stephen J. Pandol, Neil A. Bhowmick, Ekihiro Seki, Edwin M. Posadas, and Shelly C. Lu
|
| 207-208 |
|
| Correction: Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumors |
|
https://doi.org/10.18632/oncotarget.28859
Joel Ohana, Uziel Sandler, Benjamin A. Weinberg, Stephen Liu, and Yoram Devary
|
| 209-209 |
|
| Correction: β2-spectrin depletion impairs DNA damage repair |
|
https://doi.org/10.18632/oncotarget.28857
Nobuo Horikoshi, Raj K. Pandita, Kalpana Mujoo, Shashank Hambarde, Dharmendra Sharma, Abid R. Mattoo, Sharmistha Chakraborty, Vijaya Charaka, Clayton R. Hunt, and Tej K. Pandita
|
| 210-211 |
|
| Correction: A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy |
|
https://doi.org/10.18632/oncotarget.28853
Dipankar Pramanik, Nathaniel R. Campbell, Samarjit Das, Sonal Gupta, Venugopal Chenna, Savita Bisht, Polina Sysa-Shah, Djahida Bedja, Collins Karikari, Charles Steenbergen, Kathleen L. Gabrielson, Amarnath Maitra, and Anirban Maitra
|
| 212-213 |
|
| Correction: Aloeemodin as drug candidate for cancer therapy |
|
https://doi.org/10.18632/oncotarget.28870
Nadire Özenver, Mohamed Saeed, Lütfiye Ömur Demirezer, and Thomas Efferth
|
| 214-215 |
